semaglutide and aspirin New in the September 18, 2025, issue of NEJM: ⁣ ⁣ for PI3K-Altered Localized Colorectal Cancer (ALASCCA phase 3 trial) ⁣ ⁣ Orforglipron in Early Type 2 Diabetes (ACHIEVE-1 phase 3 Medications Safety Information

Shannon Chris E

These gastrointestinal effects are typically mild with the starting dose and tend to diminish within the first few weeks

Diabetes Care 36 , 914921 (2013)

Interestingly, the aryl hydrocarbon receptor (AhR) of the tryptophan-kynurenine pathway serves as a critically important mediator between tryptophan metabolism, immune reactions, and tissue homeostasis (4143), and several kynurenine metabolites have been associated with fatigue (44, 45)

Gclc f/f mice (hereafter described as Gclc WT) were also treated with tamoxifen to control for potential confounding effects associated with tamoxifen treatment

Keep in mind that individual results vary based on diet, exercise, starting weight, and overall health